Announcement
16 Jan 2025
In January 2025, US BARDA awarded USD 375 million to Shionogi Inc USD 375 million to support the development of therapeutic medication to prevent COVID-19 for immune-compromised people.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
16 Jan 2025
Revocation date:
No revocation date
Updated: 16 Jan 2025
State aid, unspecified
In force
On 16 January 2025, the Biomedical Advanced Research and Development Authority (BARDA) awarded funding to Shionogi Inc to support the development of a long-acting therapeutic medication to prevent COV...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.